Aktienanalyse wird geladen …
PFE · NYSE · Pharmaceuticals · USA
28,67 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 62,58 Mrd. | 7,77 Mrd. | 1,36 $ | 5,71 Mrd. | 27,9 Mio · 0,5 % | 14,9 Mio · 0,3 % | 74,3 % | 12,4 % | 1,59 $ | 0,14 $ | 1,72 $ |
| 2024 | 63,63 Mrd. | 8,03 Mrd. | 1,41 $ | 5,7 Mrd. | 30,6 Mio · 0,5 % | 39,6 Mio · 0,7 % | 71,9 % | 12,6 % | 1,73 $ | 0,15 $ | 1,69 $ |
| 2023 | 59,55 Mrd. | 2,12 Mrd. | 0,37 $ | 5,71 Mrd. | 18,3 Mio · 0,3 % | 42,3 Mio · 0,7 % | 58,1 % | 3,6 % | 0,84 $ | 0,09 $ | 1,65 $ |
| 2022 | 101,18 Mrd. | 31,37 Mrd. | 5,47 $ | 5,73 Mrd. | 30,4 Mio · 0,5 % | 5,4 Mio · 0,1 % | 66,1 % | 31 % | 4,54 $ | 0,15 $ | 1,61 $ |
| 2021 | 81,29 Mrd. | 21,98 Mrd. | 3,85 $ | 5,71 Mrd. | 41,2 Mio · 0,7 % | — | 62,1 % | 27 % | 5,23 $ | 0,21 $ | 1,57 $ |
| 2020 | 41,65 Mrd. | 9,16 Mrd. | 1,63 $ | 5,63 Mrd. | 26,3 Mio · 0,5 % | 69,3 Mio · 1,2 % | 79,6 % | 22 % | 2,16 $ | 0,13 $ | 1,53 $ |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|
| Q2 2026 | 15,03 Mrd. | -248 Mio. | -0,04 $ | 5,7 Mrd. | -1,7 % | 0,05 $ |
| Q1 2026 | 14,45 Mrd. | 2,69 Mrd. | 0,47 $ | 5,73 Mrd. | 18,6 % | 0,38 $ |
| Q4 2025 | 17,56 Mrd. | -1,65 Mrd. | -0,29 $ | 5,69 Mrd. | -9,4 % | 0,79 $ |
| Q3 2025 | 16,65 Mrd. | 3,54 Mrd. | 0,62 $ | 5,71 Mrd. | 21,3 % | 0,70 $ |
| Q2 2025 | 14,65 Mrd. | 2,91 Mrd. | 0,51 $ | 5,71 Mrd. | 19,9 % | -0,21 $ |
| Q1 2025 | 13,72 Mrd. | 2,97 Mrd. | 0,52 $ | 5,71 Mrd. | 21,6 % | 0,31 $ |
| Q4 2024 | 17,76 Mrd. | 410 Mio. | 0,07 $ | — | 2,3 % | 1,02 $ |
| Q3 2024 | 17,7 Mrd. | 4,47 Mrd. | 0,78 $ | 5,71 Mrd. | 25,2 % | 1,06 $ |
Pfizer (PFE) Targets Air Traffic Fees Over Unpaid Vaccines. Can it Turn a Court Win Into Cash?
AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
Pfizer Stock Paid Out $49B: So Why Did Investors Lose Money?
What Could Pfizer (PFE) Unlock From Faster FDA Reviews And Orphan Drug Growth?
Could a New Vaccine Formula XFG Give Pfizer (PFE) and BioNTech (BNTX) a Post-Pandemic Revenue Boost?
Pfizer Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and markets medicines and vaccines for people worldwide. Its current portfolio spans oncology, vaccines, internal medicine, inflammation and immunology, rare diseases, and hospital-based care, supported by a broad commercial network that serves physicians, hospitals, pharmacies, governments, and healthcare systems. Pfizer also maintains a consumer health presence through established over-the-counter and wellness products in select markets. The company plays a central role in global healthcare by supplying prescription therapies and immunizations across major therapeutic areas, while its research and development organization continues to support the launch, approval, and lifecycle management of new treatments. Founded in 1849 and headquartered in New York City, Pfizer Inc. remains one of the most recognized names in the pharmaceutical industry.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest PFE und jede andere Aktie unbegrenzt.